Skip to main content
Fig. 3 | BMC Microbiology

Fig. 3

From: Administration of Human Derived Upper gut Commensal Prevotella histicola delays the onset of type 1 diabetes in NOD mice

Fig. 3

A. Intestinal cytokine mRNA. Duodenal segments from NOD mice 18 h after an oral treatment with P. histicola (n = 4) were evaluated for the fold expression of each cytokine over no treatment (n = 4). TGFβ had almost five fold increase with P histicola treatment. B. Zo1 Intestinal Expression. 18 h after treatment with P. histicola, the duodenum was extracted and stained for ZO-1. Intensity scores were on a scale of 0–3. The treated mice (n = 3) had a non-significant increase in ZO-1 expression over untreated (n = 3)

Back to article page